Diagnosis and treatment of radiation injuries
31 Sierpnia 1998 - 31 Sierpnia 1998
Netherlands
An international conference on the diagnosis and treatment of radiation injuries will be held in Rotterdam, The Netherlands, from 31 August to 3 September 1998. The conference will be organized by the European Commission, in coooperation with the US Department of Energy, the Institut de Protection et de Sûreté Nucléaire (ISPN) and the Erasmus University, Rotterdam.
The aim of the conference is to discuss the progress made in the early diagnosis of non-homogeneous or partial body irradiation. The exposure of humans to relatively high doses of radiation occurs in medical cancer treatments, as well as due to accidents associated with the use of nuclear power, radiation devices and industrial applications. The early diagnosis of radiation injury is vital in the treatment of a patient, in order to alleviate the acute symptoms as quickly as possible and to prevent lasting damage.
In the development of treatment strategies, bone marrow transplantation has been largely replaced by growth factor therapy, although the efficiency of the growth factors has not been fully assessed. The conference will therefore focus on molecular approaches for early diagnosis and the new therapeutic modalities such as growth factor therapy, and new developments in stem cell biology, ex vivo expansion and transplantation. In addition, novel approaches to diagnosis and treatment of gastro-intestinal and skin injuries, the long-term follow-up of irradiated patients and the effects of chronic radiation exposure will also be highlighted.
For further information, please contact:
European Commission
DG XII - Science, research and development
Dr. A. Karaoglou
200 rue de la Loi (MO 75 4/14)
B-1049 Brussels
Tel. +32-2-2965415; Fax +32-2-2966256
The aim of the conference is to discuss the progress made in the early diagnosis of non-homogeneous or partial body irradiation. The exposure of humans to relatively high doses of radiation occurs in medical cancer treatments, as well as due to accidents associated with the use of nuclear power, radiation devices and industrial applications. The early diagnosis of radiation injury is vital in the treatment of a patient, in order to alleviate the acute symptoms as quickly as possible and to prevent lasting damage.
In the development of treatment strategies, bone marrow transplantation has been largely replaced by growth factor therapy, although the efficiency of the growth factors has not been fully assessed. The conference will therefore focus on molecular approaches for early diagnosis and the new therapeutic modalities such as growth factor therapy, and new developments in stem cell biology, ex vivo expansion and transplantation. In addition, novel approaches to diagnosis and treatment of gastro-intestinal and skin injuries, the long-term follow-up of irradiated patients and the effects of chronic radiation exposure will also be highlighted.
For further information, please contact:
European Commission
DG XII - Science, research and development
Dr. A. Karaoglou
200 rue de la Loi (MO 75 4/14)
B-1049 Brussels
Tel. +32-2-2965415; Fax +32-2-2966256